298 related articles for article (PubMed ID: 20133699)
1. Long-range enhancers on 8q24 regulate c-Myc.
Sotelo J; Esposito D; Duhagon MA; Banfield K; Mehalko J; Liao H; Stephens RM; Harris TJ; Munroe DJ; Wu X
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3001-5. PubMed ID: 20133699
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
3. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
4. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML
Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607
[TBL] [Abstract][Full Text] [Related]
5. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA
Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604
[TBL] [Abstract][Full Text] [Related]
6. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.
Kim T; Cui R; Jeon YJ; Lee JH; Lee JH; Sim H; Park JK; Fadda P; Tili E; Nakanishi H; Huh MI; Kim SH; Cho JH; Sung BH; Peng Y; Lee TJ; Luo Z; Sun HL; Wei H; Alder H; Oh JS; Shim KS; Ko SB; Croce CM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4173-8. PubMed ID: 24594601
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
Yochum GS; Cleland R; Goodman RH
Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
[TBL] [Abstract][Full Text] [Related]
8. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
Desbarats L; Gaubatz S; Eilers M
Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
[TBL] [Abstract][Full Text] [Related]
9. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
10. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
Ahmadiyeh N; Pomerantz MM; Grisanzio C; Herman P; Jia L; Almendro V; He HH; Brown M; Liu XS; Davis M; Caswell JL; Beckwith CA; Hills A; Macconaill L; Coetzee GA; Regan MM; Freedman ML
Proc Natl Acad Sci U S A; 2010 May; 107(21):9742-6. PubMed ID: 20453196
[TBL] [Abstract][Full Text] [Related]
11. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
Si J; Yu X; Zhang Y; DeWille JW
Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
[TBL] [Abstract][Full Text] [Related]
12. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
13. A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers.
Yochum GS; Sherrick CM; Macpartlin M; Goodman RH
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):145-50. PubMed ID: 19966299
[TBL] [Abstract][Full Text] [Related]
14. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.
Hann SR; Dixit M; Sears RC; Sealy L
Genes Dev; 1994 Oct; 8(20):2441-52. PubMed ID: 7958908
[TBL] [Abstract][Full Text] [Related]
15. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene?
Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL
Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy.
Amjadi-Moheb F; Paniri A; Akhavan-Niaki H
Cancer Res; 2021 Apr; 81(8):1925-1936. PubMed ID: 33472888
[No Abstract] [Full Text] [Related]
17. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
Prokunina-Olsson L; Hall JL
Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
[TBL] [Abstract][Full Text] [Related]
18. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation.
Perini G; Diolaiti D; Porro A; Della Valle G
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12117-22. PubMed ID: 16093321
[TBL] [Abstract][Full Text] [Related]
19. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
Arsura M; Deshpande A; Hann SR; Sonenshein GE
Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235
[TBL] [Abstract][Full Text] [Related]
20. Long-distance interaction of the integrated HPV fragment with MYC gene and 8q24.22 region upregulating the allele-specific MYC expression in HeLa cells.
Shen C; Liu Y; Shi S; Zhang R; Zhang T; Xu Q; Zhu P; Chen X; Lu F
Int J Cancer; 2017 Aug; 141(3):540-548. PubMed ID: 28470669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
